Midday immune checkpoint inhibitor (ICI) infusion influence on survival in patients with metastatic cancer: A real-world chrono-immunotherapy study.

Karaoglan B. B., KARAOĞLAN M., Yazgan S. C., BAYIR GARBİOĞLU D., DEMİR M., Aktop E., ...More

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 29 May - 02 June 2026, vol.44, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 44
  • Doi Number: 10.1200/jco.2026.44.16_suppl.11162
  • City: Illinois
  • Country: United States Of America
  • Ankara University Affiliated: Yes